With 5.2 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.78 million shares. The 52-week range on CLOV shows that it touched its highest point at $4.87 and its lowest point at $0.61 during that stretch. It currently has a 1-year price target of $4.75. Beta for the stock currently stands at 2.01.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLOV was down-trending over the past week, with a drop of -11.34%, but this was down by -11.14% over a month. Three-month performance surged to 10.06% while six-month performance rose 45.63%. The stock gained 342.67% in the past year, while it has gained 21.59% so far this year. A look at the trailing 12-month EPS for CLOV yields -0.09 with Next year EPS estimates of -0.10. For the next quarter, that number is -0.04. This implies an EPS growth rate of -80.25% for this year and 37.99% for next year. EPS is expected to grow by 40.98% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -237.67%.
Float and Shares Shorts:
At present, 395.74 million CLOV shares are outstanding with a float of 382.43 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLOV since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.11263 being high and -$0.12204 being low. For CLOV, this leads to a yearly average estimate of -$0.11849. Based on analyst estimates, the high estimate for the next quarter is $0.0 and the low estimate is $0.0. The average estimate for the next quarter is thus $0.0.
Summary of Insider Activity:
Insiders traded CLOV stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
